Waverley Pharma's latest marketcap:
As of 08/14/2025, Waverley Pharma's market capitalization has reached $588,107.17. According to our data, Waverley Pharma is the 48920th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 588,107.17 |
| Revenue (ttm) | 629,282.65 |
| Net Income (ttm) | -522,059.83 |
| Shares Out | 54 M |
| EPS (ttm) | -0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/26/2025 |
Waverley Pharma's yearly market capitalization.
| Date | Market Cap(C$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/14/2025 | C$810,000 | $588,107.17 | 50% | 48920 |
| 12/31/2024 | C$540,000 | $375,192 | -60% | 45061 |
| 12/22/2023 | C$1.35 M | $1.02 M | -16.67% | 42667 |
| 12/28/2022 | C$1.62 M | $1.19 M | -62.5% | 40879 |
| 12/30/2021 | C$4.32 M | $3.41 M | -36% | 38070 |
| 12/31/2020 | C$6.75 M | $5.3 M | 25% | 33835 |
| 11/01/2019 | C$5.4 M | $4.16 M | -64.29% | 31089 |
| 12/27/2018 | C$15.12 M | $11.07 M | -37.78% | 27540 |
| 12/29/2017 | C$24.3 M | $19.3 M | 25646 |
Company Profile
About Waverley Pharma Inc.
Waverley Pharma Inc. is a biopharmaceutical company specializing in the research, development, and commercialization of oncology therapeutics. Headquartered in Winnipeg, Canada, the company operates primarily in the United Kingdom.
Key Focus Areas
- Generic Oncology Products: Offers treatments such as temozolomide, capecitabine, and erlotinib.
- Injectable Generic Chemotherapy Drugs: Includes pemetrexed for non-small cell lung cancer and bortezomib for multiple myeloma.
- Innovative Therapies: Develops PARP-1 inhibitors for advanced cancer treatment.
Company Background
Founded in 2014, Waverley Pharma Inc. is committed to advancing oncology care through both generic and novel therapeutic solutions.
Frequently Asked Questions
-
What is Waverley Pharma's (TSXV-WAVE) current market cap?As of 08/14/2025, Waverley Pharma (including the parent company, if applicable) has an estimated market capitalization of $588,107.17 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Waverley Pharma (TSXV-WAVE) rank globally by market cap?Waverley Pharma global market capitalization ranking is approximately 48920 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.